US › Healthcare

Heart Test Laboratories Inc. Common Stock (HSCS)

US · Healthcare · Medical Devices

$2.08-2.80%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$89.5M
Revenue YoY
+2057203.0%
Net profit
$-2.8M
Profit YoY
-31.4%
EPS
$-0.88
EPS estimate
$-0.73
Net margin
-3.1%

EPS came in at -0.88 against a street estimate of -0.73 — a miss of 20.5%.

Key statistics

Market cap
$8.3M
Forward P/E
0.0
P/B
40.70
Book value
$0.07
EPS (TTM)
$-3.48
52-week high
$3.93
52-week low
$1.63
50-day MA
$2.29
200-day MA
$2.59
Beta
1.80

Analyst view

Analysts rate Heart Test Laboratories Inc. Common Stock a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $10.00.

Shareholding

Insiders
8.71%
Institutions
5.53%

Largest institutional holders

FundStake
DRW Securities, LLC2.32%
TFB Advisors LLC0.90%
Geode Capital Management, LLC0.88%
Vanguard Group Inc0.56%
Vanguard Capital Management, LLC0.55%
Vanguard Fiduciary Trust Co0.52%
Tradition Wealth Management LLC0.51%
UBS Group AG0.20%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Heart Test Laboratories Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.